Symbol="TGTX"
AssetType="Common Stock"
Name="TG Therapeutics Inc"
Description="TG Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. The company is headquartered in New York, New York."
CIK="1001316"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2 GANSEVOORT STREET, 9TH FLOOR, NEW YORK, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3022281000"
EBITDA="-162664000"
PERatio="None"
PEGRatio="0"
BookValue="0.198"
DividendPerShare="0"
DividendYield="0"
EPS="-1.22"
RevenuePerShareTTM="0.063"
ProfitMargin="0"
OperatingMarginTTM="-19.01"
ReturnOnAssetsTTM="-0.407"
ReturnOnEquityTTM="-1.704"
RevenueTTM="8572000"
GrossProfitTTM="2520000"
DilutedEPSTTM="-1.22"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="2.871"
AnalystTargetPrice="31.44"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="249.27"
PriceToBookRatio="10.88"
EVToRevenue="198.82"
EVToEBITDA="-4.349"
Beta="2.047"
num_52WeekHigh="35.67"
num_52WeekLow="4.86"
num_50DayMovingAverage="25.27"
num_200DayMovingAverage="16.78"
SharesOutstanding="149396000"
DividendDate="None"
ExDividendDate="None"
symbol="TGTX"
open="20.50"
high="20.74"
low="19.75"
price="19.82"
volume="4923800.00"
latest_trading_day="2023-07-27"
previous_close="20.23"
change="-0.41"
change_percent="-2.0267%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="8"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="92"
Volume_recent_avg="4008879"
Change_recent_avg="0.01"
Delta_recent_avg="1.47"
Variance_recent_avg="0.73"
Change_ratio_recent_avg="-0.05"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="92"
Aroon_momentum_negative="8"
image_negative_thumbnail_id_1="162"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0014.jpeg"
image_negative_thumbnail_id_2="496"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0109.jpeg"
image_neutral_thumbnail_id_1="523"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0076.jpeg"
image_neutral_thumbnail_id_2="567"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0032.jpeg"
image_positive_thumbnail_id_1="601"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0107.jpeg"
image_positive_thumbnail_id_2="697"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0011.jpeg"
image_professor_thumbnail_id_1="1188"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0022.jpeg"
image_professor_thumbnail_id_2="1195"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0029.jpeg"
